Literature DB >> 3553814

Development of inhibitors of mycobacterial ribonucleotide reductase.

K J Schaper, J K Seydel, M Rosenfeld, J Kazda.   

Abstract

Mesh：

Substances：

Year:  1986        PMID： 3553814     DOI： 10.5935/0305-7518.19860115

Source DB:  PubMed          Journal:  Lepr Rev        ISSN： 0305-7518            Impact factor:   0.537


× No keyword cloud information.
  3 in total

Review 1.  Pharmacochemical aspects of leprosy. Recent developments and prospects for new drugs.

Authors:  P van Saane; H Timmerman
Journal:  Pharm Weekbl Sci       Date:  1989-02-24

2.  Isolation of ribonucleotide reductase from Mycobacterium tuberculosis and cloning, expression, and purification of the large subunit.

Authors:  F Yang; G Lu; H Rubin
Journal:  J Bacteriol       Date:  1994-11       Impact factor: 3.490

3.  Benzothiazolyl and Benzoxazolyl Hydrazones Function as Zinc Metallochaperones to Reactivate Mutant p53.

Authors:  John A Gilleran; Xin Yu; Alan J Blayney; Anthony F Bencivenga; Bing Na; David J Augeri; Adam R Blanden; S David Kimball; Stewart N Loh; Jacques Y Roberge; Darren R Carpizo
Journal:  J Med Chem       Date:  2021-02-04       Impact factor: 8.039
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.